Share：
Share this content in WeChat
X
[Chinese][PDF]83477
• Review •
Research progress in imageology of diabetic bone marrow microangiopathy
YANG Liu  ZHA Yunfei 

Cite this article as: Yang L, Zha YF. Research progress in imageology of diabetic bone marrow microangiopathy. Chin J Magn Reson Imaging, 2019, 10(10): 787-791. DOI:10.12015/issn.1674-8034.2019.10.015.


[Abstract] Diabetic bone disease is a complication of diabetes. Diabetic patients have significantly increased risk of fracture and osteoporosis, which is difficult to cure and seriously endangers people's health. More and more studies have shown that diabetic bone disease are inseparable from microangiopathy. Imaging can evaluate bone marrow noninvasively from various aspects, such as X-ray can measure bone mineral density, CT can assess changes in bone microstructure, MRI can evaluate the perfusion of blood flow and the deposition of bone marrow fat deposition, which can provide visual imaging research evidence for the pathophysiological mechanism of diabetic bone disease. This article reviews the advances in imaging studies on the relationship between diabetic bone disease and diabetic microvascular disease on bone, bone mineral density, bone structure, bone metabolism, and risk assessment of fracture.
[Keywords] diabetes mellitus；bone marrow；microangiopathy；imageology；magnetic resonance imaging

YANG Liu Department of Radiology, Renmin Hospital of Wuhan University, Wuhan 430060, China

ZHA Yunfei * Department of Radiology, Renmin Hospital of Wuhan University, Wuhan 430060, China

*Corresponding to: Zha YF, E-mail:zhayunfei999@126.com

Conflicts of interest   None.

ACKNOWLEDGMENTS  This work was part of National Natural Science Foundation of China No. 81871332
Received  2019-07-17
DOI: 10.12015/issn.1674-8034.2019.10.015
Cite this article as: Yang L, Zha YF. Research progress in imageology of diabetic bone marrow microangiopathy. Chin J Magn Reson Imaging, 2019, 10(10): 787-791. DOI:10.12015/issn.1674-8034.2019.10.015.

[1]
Hinton PS. Role of reduced insulin-stimulated bone blood flow in the pathogenesis of metabolic insulin resistance and diabetic bone fragility. Med Hypotheses, 2016, 93(8): 81-86.
[2]
Fadini GP. Is bone marrow another target of diabetic complications?. Eur J Clin Invest, 2011, 41(4): 457-463.
[3]
Fadini GP, Ferraro F, Quaini F, et al. Concise review: diabetes, the bone marrow niche, and impaired vascular regeneration. Stem Cells Transl Med, 2014, 3(8): 949-957.
[4]
Shanbhogue VV, Hansen S, Frost M, et al. Bone disease in diabetes: another manifestation of microvascular disease?. Lancet Diabetes Endocrinol, 2017, 5(10): 827-838.
[5]
Fajardo RJ. Is diabetic skeletal fragility associated with microvascular complications in bone?. Curr Osteoporos Rep, 2017, 15(1): 1-8.
[6]
Oikawa A, Siragusa M, Quaini F, et al. Diabetes mellitus induces bone marrow microangiopathy. Arterioscler Thromb Vasc Biol, 2010, 30(3): 498-508.
[7]
Armas LA, Akhter MP, Drincic A, et al. Trabecular bone histomorphometry in humans with type 1 diabetes mellitus. Bone, 2012, 50(1): 91-96.
[8]
Ma L, Oei L, Jiang L, et al. Association between bone mineral density and type 2 diabetes mellitus: a meta-analysis of observational studies. Eur J Epidemiol, 2012, 27(5): 319-332.
[9]
Shanbhogue VV, Mitchell DM, Rosen CJ, et al. Type 2 diabetes and the skeleton: new insights into sweet bones. Lancet Diabetes Endocrinol, 2016, 4(2): 159-173.
[10]
Shanbhogue VV, Hansen S, Frost M, et al. Bone geometry, volumetric density, microarchitecture, and estimated bone strength assessed by HR- pQCT in adult patients with type 1 diabetes mellitus. J Bone Miner Res, 2015, 30(12): 2188-2199.
[11]
Yu EW, Putman MS, Derrico N, et al. Defects in cortical microarchitecture among African-American women with type 2 diabetes. Osteoporos Int, 2015, 26(2): 673-679.
[12]
Harvey NC, Gluer CC, Binkley N, et al. Trabecular bone score (TBS) as a new complementary approach for osteoporosis evaluation in clinical practice. Bone, 2015, 78(9): 216-224.
[13]
Farr JN, Khosla S. Determinants of bone strength and quality in diabetes mellitus in humans. Bone, 2016, 82(1): 28-34.
[14]
Zhong N, Zhang Y, Pu X, et al. Microangiopathy is associated with bone loss in female type 2 diabetes mellitus patients. Diab Vasc Dis Res, 2018, 15(5): 433-441.
[15]
Viegas M, Costa C, Lopes A, et al. Prevalence of osteoporosis and vertebral fractures in postmenopausal women with type 2 diabetes mellitus and their relationship with duration of the disease and chronic complications. J Diabetes Complications, 2011, 25(4): 216-221.
[16]
Stabley JN, Prisby RD, Behnke BJ, et al. Type 2 diabetes alters bone and marrow blood flow and vascular control mechanisms in the ZDF rat. J Endocrinol, 2015, 225(1): 47-58.
[17]
Zeitoun D, Caliaperoumal G, Bensidhoum M, et al. Microcomputed tomography of the femur of diabetic rats: alterations of trabecular and cortical bone microarchitecture and vasculature-a feasibility study. Eur Radiol Exp, 2019, 3(1): 17.
[18]
Xing D, Zha Y, Yan L, et al. Feasibility of ASL spinal bone marrow perfusion imaging with optimized inversion time. J Magn Reson Imaging, 2015, 42(5): 1314-1320.
[19]
Zhu J, Zhang L, Wu X, et al. Reduction of longitudinal vertebral blood perfusion and its likely causes: A quantitative dynamic contrastenhanced MR imaging study of a rat osteoporosis model. Radiology, 2017, 282(2): 369-380.
[20]
Hu L, Zha YF, Wang L, et al. Quantitative evaluation of vertebral microvascular permeability and fat fraction in alloxan-induced diabetic rabbits. Radiology, 2018, 287(1): 128-136.
[21]
Yamamoto M, Sugimoto T. Advanced glycation end products, diabetes, and bone strength. Curr Osteoporos Rep, 2016, 14(6): 320-326.
[22]
Marin C, Papantonakis G, Sels K, et al. Unraveling the compromised biomechanical performance of type 2 diabetes- and Roux-en-Y gastric bypass bone by linking mechanical-structural and physico-chemical properties. Sci Rep, 2018, 8(1): 5881.
[23]
Koike S, Yano S, Tanaka S, et al. Advanced glycation end-products induce apoptosis of vascular smooth muscle cells: A mechanism for vascular calcification. Int J Mol Sci, 2016, 17(9): E1567.
[24]
Wang Z, Li L, Du R, et al. CML/RAGE signal induces calcification cascade in diabetes. Diabetol Metab Syndr, 2016, 8(12): 83.
[25]
Marin C, Luyten FP, Van der Schueren B, et al. The impact of type 2 diabetes on bone fracture healing. Front Endocrinol (Lausanne), 2018, 9(1): 6.
[26]
Sukmawati D, Tanaka R. Introduction to next generation of endothelial progenitor cell therapy: a promise in vascular medicine. Am J Transl Res, 2015, 7(3): 411-421.
[27]
Makino H, Miyamoto Y, Kikuchi-Taura A, et al. Decreased levels of circulating CD34(+) cells are associated with coronary heart disease in Japanese patients with type 2 diabetes. J Diabetes Investig, 2015, 6(4): 473-478.
[28]
Mohler ER, Shi Y, Moore J, et al. Diabetes reduces bone marrow and circulating porcine endothelial progenitor cells, an effect ameliorated by atorvastatin and independent of cholesterol. Cytometry A, 2009, 75(1): 75-82.
[29]
谭强，李广平，王庆胜，等．四氧嘧啶诱导的糖尿病对兔骨髓内皮祖细胞及循环内皮祖细胞功能的影响．中华医学杂志, 2017, 97(28): 2186-2193.
[30]
Clarkin CE, Gerstenfeld LC. VEGF and bone cell signalling: an essential vessel for communication?. Cell Biochem Funct, 2013, 31(1): 1-11.
[31]
Shibuya M. Vascular endothelial growth factor (VEGF) and its receptor (VEGFR) signaling in angiogenesis: A crucial target for anti- and proangiogenic therapies. Genes Cancer, 2011, 2(12): 1097-1105.
[32]
Lombardo MF, Iacopino P, Cuzzola M, et al. Type 2 diabetes mellitus impairs the maturation of endothelial progenitor cells and increases the number of circulating endothelial cells in peripheral blood. Cytometry A, 2012, 81(10): 856-864.
[33]
Scheller EL, Rosen CJ. What's the matter with MAT? Marrow adipose tissue, metabolism, and skeletal health. Ann N Y Acad Sci, 2014, 1311: 14-30.
[34]
Schafer AL, Li X, Schwartz AV, et al. Changes in vertebral bone marrow fat and bone mass after gastric bypass surgery: A pilot study. Bone, 2015, 74(5): 140-145.
[35]
Devlin MJ, Van Vliet M, Motyl K, et al. Early-onset type 2 diabetes impairs skeletal acquisition in the male TALLYHO/JngJ mouse. Endocrinology, 2014, 155(10): 3806-3816.
[36]
Kim TY, Schafer AL. Diabetes and bone marrow adiposity. Curr Osteoporos Rep, 2016, 14(6): 337-344.
[37]
Baum T, Yap SP, Karampinos DC, et al. Does vertebral bone marrow fat content correlate with abdominal adipose tissue, lumbar spine bone mineral density, and blood biomarkers in women with type 2 diabetes mellitus?. J Magn Res Imaging, 2012, 35(1): 117-124.
[38]
Patsch JM, Li X, Baum T, et al. Bone marrow fat composition as a novel imaging biomarker in postmenopausal women with prevalent fragility fractures. J Bone Miner Res, 2013, 28(8): 1721-1728.
[39]
Yu EW, Greenblatt L, Eajazi A, et al. Marrow adipose tissue composition in adults with morbid obesity. Bone, 2017, 97(4): 38-42.
[40]
Aoki T, Yamaguchi S, Kinoshita S, et al. Quantification of bone marrow fat content using iterative decomposition of water and fat with echo asymmetry and least-squares estimation (IDEAL): reproducibility, site variation and correlation with age and menopause. Br J Radiol, 2016, 89(1065): 20150538.
[41]
Idilman IS, Tuzun A, Savas B, et al. Quantification of liver, pancreas, kidney, and vertebral body MRI-PDFF in non-alcoholic fatty liver disease. Abdom Imaging, 2015, 40(6): 1512-1519.
[42]
金斌，李选．糖尿病合并周围血管病变的下肢骨骼肌CT灌注成像特征．中华放射学杂志, 2015, 49(1): 16-19.
[43]
Teraa M, Fledderus JO, Rozbeh RI, et al. Bone marrow microvascular and neuropathic alterations in patients with critical limb ischemia. Circ Res, 2014, 114(2): 311-314

PREV Progress of diffusion imaging in neonatal hypoxic-ischemic encephalopathy
NEXT Present situations and prospects of magnetic resonance imaging in the evaluation of treatment response of cervical cancer
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn